PEG 3350 Long-term Therapy:To Achieve Functional Constipation Treatment Goals

ESPGHAN: European Society for Paediatric Gastroenterology Hepatology and Nutrition; IAP: Indian Academy of Pediatrics; NASPGHAN: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; PEG: Polyethylene glycol.

1. Pashankar DS, Loening-Baucke V, Bishop WP. Safety of polyethylene glycol 3350 for the treatment of chronic constipation in children. Arch Pediatr Adolesc Med. 2003;157(7):661–664. 2. Dheivamani N, Thomas W, Bannerjii R, et al. Efficacy of polyethylene glycol 3350 as compared to lactulose in treatment of ROME IV criteria-defined pediatric functional constipation: A randomized controlled trial. Indian J Gastroenterol. 2021;40(2):227–233. 3. Yachha SK, Srivastava A, Mohan N, et al. Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition Committee on Childhood Functional Constipation, and Pediatric Gastroenterology Subspecialty Chapter of Indian Academy of Functional Constipation, and Pediatric Gastroenterology Subspecialty Chapter of Indian Academy of Pediatrics. Management of Childhood Functional Constipation: Consensus Practice Guidelines of Indian Society of Pediatric Gastroenterology. Indian Pediatr. 2018;55(10):885–892. 4. Tabbers MM, DILorenzo C, Berger MY, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition: North American Society for Pediatric Gastroenterology. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58(2):258–274.